Israeli given $69MILLION to make coronavirus ventilators after tweeting Trump , 0 delivered

[enhanced_deficit]

How would reports like this impact public perceptions about current leadership's big debt spending?


Israeli said to con NY State out of $69m on promise to supply ventilators
timesofisrael
9 hours ago - Yaron Oren-Pines, a Silicon Valley electrical engineer with no medical experience, tweeted in reply to US President Donald Trump that “we can ...

HOT AIR
Tycoon given $69MILLION to make coronavirus ventilators after tweeting Donald Trump hasn’t delivered a single one

Christy Cooney
Apr 30 2020, 4:39 ET
A SILICON Valley entrepreneur who was given $69million to deliver ventilators after tweeting at Donald Trump has reportedly failed to deliver a single one.
Yaron Oren-Pines, an electrical engineer who works in mobile technology, was sent the payment by New York state after asking the president to have someone contact him "urgently" on March 27.

Entrepreneur Yaron Oren-Pines was given $69million to deliver ventilators but has reportedly failed to deliver a single one Oren-Pines was sent the funds after responding to a tweet from President TrumpCredit: AFP
Oren-Pines was responding to a call from the president for major car manufacturers to reopen plants to help meet the surge in demand for ventilators amid the coronavirus pandemic.
"START MAKING VENTILATORS, NOW!!!!!!" Trump wrote, tagging in the twitter accounts of Ford and General Motors.
Oren-Pines, the founder and CEO of a quality assurance testing house named In-Common, replied: "We can supply ICU Ventilators, invasive and noninvasive.
"Have someone call me URGENT."
Three days later, the state of New York sent the businessman $69million to provide 1,450 ventilators but a month later he is yet to deliver a single one, BuzzFeed News reported.
The money paid for the ventilators worked out at $47,656 each, more than triple the normal price for a high-end model.
The funds were the single largest payment that the Department of Health in New York, the US's worst-hit state, has made in its efforts to procure the supplies needed for its health and emergency service to tackle the pandemic.
Reached on the phone by Buzzfeed News, Oren-Pines said: "Neither me nor my company is providing any comment on this."

https://www.the-sun.com/news/758994/tycoon-coronavirus-ventilators-tweeting-donald-trump-delivered/




Related

March 17, 2020
Israeli Spyware Firm Wants to Track Data to Stop Coronavirus Spreading

 

[enhanced_deficit]

Silverlining here may be that any political impact of recent reports about US debt spiking to $25 Trillions should not be too bad... as Tea Party probably may have been in quarantine these days following strong MAGA leadership response to non-hoax developments.

Tea Party Revolts Against Obama's Budget
thefiscaltimes
Feb 4, 2016

 

[enhanced_deficit]

Taxpayers funded "bridges to nowhere" to reward political donors linked cronies back in the play?

Triumphant Netanyahu Teases Blockbuster Alliance with Tesla's Elon Musk

Mar 21, 2018 - Musk met with Israeli Prime Minister Benjamin Netanyahu at his private residence


SpaceX Moon Contract Could Be Worth $7 Billion -- Or Nothing

How much is a contract to deliver supplies to an imaginary space station worth?

Rich Smith
May 3, 2020

NASA's award of $1 billion in contracts to Blue Origin, Dynetics, and SpaceX to build landers to carry astronauts back to the moon is dominating headlines this week -- and don't get me wrong, this is a really big deal. But it pales in comparison to another NASA contract that SpaceX won just a little over a month ago.

That contract, to provide logistics services to a planned Lunar Gateway space station orbiting the moon, could be worth as much as $7 billion -- and SpaceX might not have to share it with anyone.

fool.com/investing/2020/05/03/spacex-moon-contract-could-be-worth-7-billion-or-n.aspx

 

[enhanced_deficit]

With FDA approval in hand and Covid-19 as a test case, Israel’s Clew is ready for its money time

“This is a product we have been working on for years and from that perspective, Covid-19 showcased everything we have been saying,” says CEO Gal Salomon

23.06.20

There is a moment in the life of every successful company when everything finally falls into place. It is still too early to label Clew Medical Ltd. as a fully-fledged success, but there is little doubt that should the Israeli startup realize its wildest dreams, it will look back at the past six months as the turning point that launched it on the road to entrepreneurial glory.

The company received the Emergency Use Authorization (EUA), which is being issued by the FDA to help battle the pandemic, for its ICU (Intensive Care Unit) solution which uses predictive screening information to help identify patients with common complications associated with coronavirus.

But Clew has been around long before anyone even heard of Covid-19. That is only one particular use-case for its AI (Artificial Intelligence) and machine learning technology, with the company beginning the research and development of its current products back in 2015.

"Covid-19 took everything that the company has been talking about for years and proved it in practice. We couldn't have expected anything better," Clew CEO Gal Salomon told CTech earlier this week. "For example, one of the problems with coronavirus patients is that they are very infectious. It became clear that you can't just send unprotected medical staff to treat them. So hospitals created command and control centers in which the doctors sit and make decisions according to all the analyzed information they receive and relay instructions to the protected medical staff treating the patients.
This is a product we have been working on for years and from that perspective, Covid-19 showcased everything we have been saying."

Clew's models were developed based on information from hundreds of thousands of patients treated in a large number of hospitals in the U.S., the company's target market. "We have been working on this data for several years to determine what were the reasons that caused a certain patient to reach a certain condition," said Salomon. "In order to receive approval from the FDA you have to conduct a vast number of experiments and explain how you built your models and how you tested them. You need to show that your results are applicable to the entire population and that your product worked in several hospitals."

Salomon said the green light from the FDA serves as the ultimate approval to begin selling their product. "Until you get their approval you can't move into the commercial phase. So now this is our money time. Investors put up tens of millions of dollars and they want to ultimately see a return on their investment once the company has a commercial product and we are now entering this phase," he said.

Clew, which employees 36 people in all, 33 of them in Israel, will also be expanding its workforce soon as it looks to promote and integrate its products in U.S. hospitals. The focus at the moment is on selling CLEWICU, but Salomon has far greater aspirations for his company.

calcalistech.com/ctech/articles/0,7340,L-3835412,00.html



Hopefully hospitals visited by US foreign aid managing congress members was not part of such programs and any data they took won't be stolen/abused as apparently was a concern for other Americans data as was investigated in a pre-MAGA Foxnews report on espionage.


https://www.youtube.com/watch?v=GnWSNI7rKf0